Biolife Solutions (BLFS) Research & Development (2010 - 2026)

Biolife Solutions (BLFS) has reported Research & Development for 17 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 14.78% year-over-year to $3.0 million in Q2 2026; TTM through Jun 2026 was $10.3 million, a 13.38% increase from a year earlier, with the FY2025 full-year figure at $9.8 million, up 10.28% from the prior year.
• Research & Development was $3.0 million for Q2 2026 at Biolife Solutions, up from $2.6 million in the prior quarter.
• Over five years, Research & Development peaked at $6.5 million in Q1 2023 and troughed at -$3.9 million in Q4 2022.
• A 5-year average of $2.8 million and a median of $2.6 million in 2025 frame the typical range for Research & Development.
• Across the five-year window, Research & Development plunged 182.23% in 2022 and soared 215.66% in 2024, its largest moves.
• Over 5 years, Research & Development stood at -$3.9 million in 2022, then surged by 65.54% to -$1.4 million in 2023, then soared by 215.66% to $1.6 million in 2024, then grew by 27.27% to $2.0 million in 2025, then soared by 48.42% to $3.0 million in 2026.
• The last three Research & Development figures came in at $3.0 million (Q2 2026), $2.6 million (Q1 2026), and $2.0 million (Q4 2025), per Business Quant data.